Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
MICIT
Fourth Extension - Granted
Show more
Class 5: Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and proteins, namely, pharmaceutical preparations for treatment of cancer
Class 9: Scientific apparatus and instruments, namely, downloadable mobile software applications for personalized cancer patient information; Software algorithms, namely, downloadable software programs for detecting and registering mutations in cancer patients
Class 10: Medical devices, namely, high-throughput analysis devices for next-generation sequencing for gene expression profiling and for the detection of epigenetic changes
Class 42: Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Scientific laboratory services and scientific research for medical purposes in the field of oncology, namely, diagnostics of tumor markers for personalized therapy
Class 44: Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Medical services, namely, conducting analyzes and treatments in the field of personalized cancer immunotherapy; Medical services, namely, providing nucleic acid based therapies and checkpoint inhibitors
Class 5 – Pharmaceuticals & supplementsClass 9 – Software, electronics & scientificClass 10 – Medical apparatusClass 42 – Technology & SaaSClass 44 – Medical & beauty services
Status timeline
- 30 Sep 2023Application filedNew Application Entered
- 20 May 2024Assigned to an examining attorneyAssigned To Examiner
- 28 May 2024Approved for publicationApproved For Pub - Principal Register
- 2 Jul 2024Published for oppositionPublished For Opposition
- 27 Aug 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 9 Dec 2024Statement-of-use extension 1 grantedSou Extension 1 Granted
- 12 Aug 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 14 Jan 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 28 events
| 2026-08-25 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-08-24 | Sou Teas Extension Received |
| 2026-08-24 | Sou Extension 4 Filed |
| 2026-08-24 | Sou Extension 4 Granted |
| 2026-01-15 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-01-14 | Sou Teas Extension Received |
| 2026-01-14 | Sou Extension 3 Filed |
| 2026-01-14 | Sou Extension 3 Granted |
| 2025-08-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-08-12 | Sou Teas Extension Received |
| 2025-08-12 | Sou Extension 2 Filed |
| 2025-08-12 | Sou Extension 2 Granted |
| 2025-03-03 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-12-09 | Sou Teas Extension Received |
| 2024-12-09 | Sou Extension 1 Filed |
| 2024-12-09 | Sou Extension 1 Granted |
| 2024-08-27 | Noa Mailed - Sou Required From Applicant |
| 2024-07-02 | Published For Opposition |
| 2024-07-02 | Official Gazette Publication Confirmation E-Mailed |
| 2024-06-12 | Notification Of Notice Of Publication E-Mailed |
| 2024-05-28 | Examiners Amendment -Written |
| 2024-05-28 | Examiners Amendment E-Mailed |
| 2024-05-28 | Notification Of Examiners Amendment E-Mailed |
| 2024-05-28 | Examiner's Amendment Entered |
| 2024-05-28 | Approved For Pub - Principal Register |
| 2024-05-20 | Assigned To Examiner |
| 2023-10-11 | New Application Office Supplied Data Entered |
| 2023-09-30 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of cancer, in particular based on nucleic acids and/or proteins; Medicines individually tailored for the respective patient, in particular based on nucleic acids and proteins, namely, pharmaceutical preparations for treatment of cancer
Class 9 Software, electronics & scientific
Scientific apparatus and instruments, namely, downloadable mobile software applications for personalized cancer patient information; Software algorithms, namely, downloadable software programs for detecting and registering mutations in cancer patients
Class 10 Medical apparatus
Medical devices, namely, high-throughput analysis devices for next-generation sequencing for gene expression profiling and for the detection of epigenetic changes
Class 42 Technology & SaaS
Research and development in the field of cancer immunotherapy, in particular research and development in the field of human and veterinary medical diagnostics and therapy using molecular biological, genetic engineering, biotechnological and/or bioinformatic methods, in particular using next-generation sequencing; Scientific laboratory services and scientific research for medical purposes in the field of oncology, namely, diagnostics of tumor markers for personalized therapy
Class 44 Medical & beauty services
Medical, veterinary and pharmaceutical consultancy, in particular with regard to the selection of suitable therapies for all types of cancer; Medical services, namely, conducting analyzes and treatments in the field of personalized cancer immunotherapy; Medical services, namely, providing nucleic acid based therapies and checkpoint inhibitors
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 25 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.